GLYCOMIMETICS INC (GLYC) has 60 open-market insider trades by 26 insiders since 2014. The most active filer is Scott D. Sandell, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Scott D. Sandell | 10% Owner | — | 6 | $34.1M | 2023-01-26 |
| Biotechnology VALUE FUND II L.P. | 10% Owner | — | 1 | $10.6M | 2019-09-05 |
| BVF Inc/il | 10% Owner | — | 2 | $10.1M | 2020-11-04 |
| M. James Barrett | Dir10% Owner | — | 3 | $8.3M | 2018-05-10 |
| Peter J. Barris | 10% | — | 3 | $8.2M | 2018-05-10 |
| NEW Enterprise Associates 13 L.P. | 10% | — | 1 | $4.1M | 2014-01-15 |
| NEA Partners 10 L P | 10% | — | 1 | $3.9M | 2014-01-15 |
| Amaury Wittouck | 10% Owner | — | 3 | $3.8M | 2023-02-24 |
| Siren, L.L.C. | 10% Owner | — | 3 | $764K | 2024-08-08 |
| Brian M. Hahn | CFO | — | 5 | $734K | 2024-06-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Siren, L.L.C. | 10% | Sell | $61K | 2024-08-07 |
| Invus Public Equities Advisors, LLC | 10% | Sell | $41K | 2024-08-05 |
| Siren, L.L.C. | 10% Owner | Sell | $71K | 2024-08-01 |
| Siren, L.L.C. | 10% Owner | Sell | $632K | 2024-07-26 |
| Edwin Rock | Chief Medical Officer | Buy | $79K | 2024-06-20 |
| Brian M. Hahn | CFO & SVP Finance | Buy | $4K |
Companies that share insiders with GLYC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-06-18 |
| Edwin Rock | Chief Medical Officer | Buy | $90K | 2023-09-21 |
| Brian M. Hahn | CFO & SVP Finance | Sell | $7K | 2023-05-17 |
| Daniel M. Junius | Director | Buy | $47K | 2023-05-10 |
| Bruce S. Johnson | SVP & Chief Commercial Officer | Buy | $21K | 2023-05-08 |
| Amaury Wittouck | 10% Owner | Buy | $170K | 2023-02-24 |
| Artal Group S.A. | 10% Owner | Buy | $711K | 2023-02-21 |
| Amaury Wittouck | 10% Owner | Buy | $3.6M | 2023-02-15 |
| Amaury Wittouck | 10% | Buy | $37K | 2023-02-09 |
| Scott D. Sandell | 10% Owner | Sell | $23.0M | 2023-01-25 |